Specific Biomarker Test for Early Sepsis Identification Introduced

EKF Diagnostics, the global diagnostics company, announces that it has introduced the Stanbio Chemistry Procalcitonin (PCT) LiquiColor® Assay. This new test enables the quantitative determination of PCT in serum samples, EDTA or lithium heparin plasma samples by latex enhanced immunoturbidimetric methodology. Procalcitonin is a marker for bacterial infection and sepsis and has been recognised as an important adjunct marker in the diagnosis of sepsis.

The new Stanbio Chemistry Procalcitonin (PCT) LiquiColor® Assay is fast, accurate and convenient. The test provides a precise result, which correlates well with established methodology, within 10 minutes and requires just 20 µL of sample. The reagents may be used on almost any liquid-based chemistry analyser with open-channel capability. In addition, the reagent kit, calibrator and control sets are all available separately.

Commenting on the cost-effectiveness and convenience of the Stanbio Chemistry Procalcitonin (PCT) LiquiColor® Assay, Al Blanco, Business Unit Director – Central Laboratory at EKF Diagnostics said, “This assay can be performed on a customer’s existing chemistry analyser with the same collection tube used for analysis of other chemistry tests.  Therefore, it will provide optimised lab workflow by eliminating the need to split a sample or have a dedicated off-line workstation. These features will provide any lab with a cost-effective solution for PCT testing.”

For more information on Procalcitonin and sepsis testing, the Stanbio Chemistry range or EKF Diagnostics, please visit www.ekfdiagnostics.com.